Furthermore, cumulative evidence suggests that cognate interactions between CD95L and CD95 may likewise prompt non-apoptotic tumor-promoting features such as proliferation, invasiveness and stemness in CD95-expressing cancer cells [7–12] in various malignancies including glioblastoma [13–15]. The gene discussed is FASLG; the disease is cancer.